Literature DB >> 36258729

Double Philadelphia Chromosomes- A Rare, Yet an Important Cytogenetic Phenomenon of Prognostic Significance in De Novo Acute Lymphoblastic Leukemia.

Shanthala Siddappa1, Syed Adil Hassan2, Kavitha B Lingappa1, L K Rajeev2, M Padma3, Lokanatha Dasappa2.   

Abstract

Presence of additional copies of Philadelphia chromosome (Ph) is characteristic of chronic myeloid leukemia in blast crisis, very rarely observed in de novo acute lymphoblastic leukemia (ALL). Ph positive (Ph+ve) ALL and CML in lymphoid blast crisis (CML-LBC) are biologically different with divergent clinical course. Double Ph+ve ALL has little data available as to its incidence and prognostic significance. We studied five cases of Ph+ve precursor B-cell ALL having an extra copy of Ph chromosome with regard to their clinical and laboratory features. An extensive review of literature was done on prognostic significance and molecular aspects of double Ph in ALL. The study confirms that double Ph was a rare phenomenon in precursor B-cell ALL. It is observed that molecular basis of double Ph positive ALL is less understood compared to CML in blast crisis. The study highlights fundamental role of cytogenetic and molecular studies in diagnosis and management of these patients. Long-term follow-up studies on a larger group of patients are required to understand the prognostic impact of extra Ph in Ph+ve ALL, which is usually resistant to standard chemotherapeutic regimen and often requiring bone marrow transplantation. Supplementary Information: The online version contains supplementary material available at 10.1007/s12288-022-01525-1. © Indian Society of Hematology and Blood Transfusion 2022.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Double Ph positive

Year:  2022        PMID: 36258729      PMCID: PMC9569261          DOI: 10.1007/s12288-022-01525-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.915


  16 in total

1.  Double Philadelphia chromosomes-positive acute lymphocytic leukemia.

Authors:  Hirotaka Takasaki; Heiwa Kanamori; Maki Takabayashi; Satoshi Yamaji; Naoto Tomita; Katsumichi Fujimaki; Shin Fujisawa; Yoshiaki Ishigatsubo
Journal:  Leuk Lymphoma       Date:  2003-04

Review 2.  The biology of CML blast crisis.

Authors:  Bruno Calabretta; Danilo Perrotti
Journal:  Blood       Date:  2004-02-24       Impact factor: 22.113

Review 3.  The legacy of the Philadelphia chromosome.

Authors:  Gary A Koretzky
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

4.  Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia.

Authors:  H Rieder; W D Ludwig; W Gassmann; J Maurer; J W Janssen; N Gökbuget; S Schwartz; E Thiel; H Löffler; C R Bartram; D Hoelzer; C Fonatsch
Journal:  Br J Haematol       Date:  1996-12       Impact factor: 6.998

Review 5.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

6.  Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib.

Authors:  Barbara Wassmann; Heike Pfeifer; Urban J Scheuring; Anja Binckebanck; Nicola Gökbuget; Johannes Atta; Patrick Brück; Harald Rieder; Claudia Schoch; Lothar Leimer; Rainer Schwerdtfeger; Gerhard Ehninger; Thomas Lipp; Jolanta Perz; Matthias Stelljes; Harald Gschaidmeier; Dieter Hoelzer; Oliver G Ottmann
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

7.  Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group.

Authors:  F M Uckun; J B Nachman; H N Sather; M G Sensel; P Kraft; P G Steinherz; B Lange; R Hutchinson; G H Reaman; P S Gaynon; N A Heerema
Journal:  Cancer       Date:  1998-11-01       Impact factor: 6.860

8.  Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.

Authors:  X Thomas; A Thiebaut; N Olteanu; C Danaïla; C Charrin; E Archimbaud; D Fiere
Journal:  Hematol Cell Ther       Date:  1998-06

9.  Additional chromosomal abnormalities in Philadelphia-positive chronic myeloid leukemia.

Authors:  Naveen Naz Syed; Mohammad Usman; Salman Adil; Mohammad Khurshid
Journal:  Hematol Oncol Stem Cell Ther       Date:  2008 Jul-Sep

10.  Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia.

Authors:  Ramachandran Krishna Chandran; Narayanan Geetha; Kunnathur Murugesan Sakthivel; Raveendran Suresh Kumar; Kumarapillai Mohanan Nair Jagathnath Krishna; Hariharan Sreedharan
Journal:  Front Oncol       Date:  2019-03-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.